Independent radiologic review of the Gynecologic Oncology Group Study 0218, a phase III trial of bevacizumab in the primary treatment of advanced epithelial ovarian, primary peritoneal, or fallopian tube cancer

OBJECTIVES: Gynecologic Oncology Group Study 0218 (GOG-0218), a phase III, placebo-controlled trial in newly diagnosed stage III/IV ovarian cancer (OC), demonstrated a benefit in investigator (INV)-assessed progression-free survival (PFS) with bevacizumab (BEV) administered with and following carbop...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Burger, Robert. A., Brady, Mark F., Rhee, Joon, Sovak, Mika A., Kong, George, Nguyen, Hoa P., Bookman, Michael A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3795907/
https://ncbi.nlm.nih.gov/pubmed/23906656
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2013.07.100
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados